Our urology department is concerned with the surgical treatment of cancer in the urinary tract in both men and women, as well as cancer of the male sexual organs. The department also deals with urologic complications as a result of treatment for other types of cancer.
Our work methods
Your treatment will be determined during a multidisciplinary team meeting involving other specialists and colleagues. Your tumor may need to be surgically removed, and you may need chemotherapy or radiotherapy before or after your surgery.
Your urologist will invite you to come in for checkups after your treatment. This helps us detect a potential recurrence on time, and adequately treat or prevent potential complications or long-term effects. If you are experiencing urologic complications after your treatment, our urologists can help you.
Clinical nurse specialists, assistants in training, and fellows
Several clinical nurse specialists work at the Urology department. They can offer more information about the various possibilities and will guide you during your treatment. Our department also employs assistants trained in urology and fellows (urologists looking to specialize in oncology).
Our treatment team
Our specialists are experts in the field of urologic oncology
Urologists and clinical nurse specialists
Matteo DroghettiUrologist | Fellow
Nadia van GalenNurse Practitioner in training
Maaike van de KampUrologist
Pim van LeeuwenUrologist
Laura MertensUrologist | Fellow
Mariëlle OosterveerNurse Practitioner
Henk van der PoelUrologist
Bas van RhijnUrologist
Jolien van KesterenClinical nurse specialist in training
Jeroen VisserNurse practitioner
Erik van MuilekomNurse practitioner
Corinne TillierNurse practitioner
Medical oncologists and clinical nurse specialists
Radiation oncologists and Physician Assistants
Nuclear medicine specialists
Find more information about our preclinical and clinical trials at the Urology department on this page.
- Signal transduction pathways in hormonal refractory prostate cancer;
- Development of a tumor model for bladder and prostate carcinoma using conditional gene expression and gene deletions.
- Optimizing tissue-sparing treatment;
- Detection of metastases;
- Improvements of prognosis possibilities at the start of cancer treatment;
- Sentinel node biopsies in all urologic tumors, using minimally invasive procedures;
- Optimizing the use of robotic surgery in uro-oncological procedures. This research focuses on the possibilities of intraoperative navigation through the use of any imaging modalities possible as well as experimental modalities in the form of molecular imagers.